| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |